ATE282625T1 - Gaba-c-rezeptor-antagonisten zur stimulation des erinnerungsvermögens - Google Patents
Gaba-c-rezeptor-antagonisten zur stimulation des erinnerungsvermögensInfo
- Publication number
- ATE282625T1 ATE282625T1 AT98929133T AT98929133T ATE282625T1 AT E282625 T1 ATE282625 T1 AT E282625T1 AT 98929133 T AT98929133 T AT 98929133T AT 98929133 T AT98929133 T AT 98929133T AT E282625 T1 ATE282625 T1 AT E282625T1
- Authority
- AT
- Austria
- Prior art keywords
- pdat
- gaba
- receptor antagonists
- hil
- compound
- Prior art date
Links
- 229940122557 GABA C receptor antagonist Drugs 0.000 title 1
- 101710133727 Phospholipid:diacylglycerol acyltransferase Proteins 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000000694 effects Effects 0.000 abstract 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 abstract 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000002464 receptor antagonist Substances 0.000 abstract 2
- 229940044551 receptor antagonist Drugs 0.000 abstract 2
- 206010012289 Dementia Diseases 0.000 abstract 1
- 230000007278 cognition impairment Effects 0.000 abstract 1
- 230000001149 cognitive effect Effects 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 206010027175 memory impairment Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- ACVYVLVWPXVTIT-UHFFFAOYSA-N phosphinic acid Chemical group O[PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-N 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Laminated Bodies (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPO7501A AUPO750197A0 (en) | 1997-06-23 | 1997-06-23 | Neurologically-active compounds |
| AUPP2985A AUPP298598A0 (en) | 1998-04-17 | 1998-04-17 | Neurologically-active compounds |
| PCT/AU1998/000485 WO1998058939A1 (en) | 1997-06-23 | 1998-06-23 | Neurologically-active compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE282625T1 true ATE282625T1 (de) | 2004-12-15 |
Family
ID=25645454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98929133T ATE282625T1 (de) | 1997-06-23 | 1998-06-23 | Gaba-c-rezeptor-antagonisten zur stimulation des erinnerungsvermögens |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6632806B1 (de) |
| EP (1) | EP1000071B1 (de) |
| AT (1) | ATE282625T1 (de) |
| AU (2) | AU744189B2 (de) |
| DE (1) | DE69827635T2 (de) |
| WO (1) | WO1998058939A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9906882D0 (en) * | 1999-03-25 | 1999-05-19 | Novartis Ag | Organic compounds |
| JP2004532200A (ja) * | 2001-03-15 | 2004-10-21 | サエジス ファーマシューティカルズ， インコーポレイテッド | 全身性ストレスの後に認識機能を回復するための方法 |
| AUPR920301A0 (en) | 2001-11-30 | 2001-12-20 | Polychip Pharmaceuticals Pty Ltd | Neurologically-active compounds |
| WO2004002399A2 (en) * | 2002-06-28 | 2004-01-08 | Novartis Ag | Use of gaba-c receptor antagonists for the treatment of myopia |
| AU2002320959A1 (en) * | 2002-07-02 | 2004-01-23 | Gumlink As | Compressed chewing gum tablet ii |
| ITSV20030019A1 (it) * | 2003-04-11 | 2004-10-12 | Allaix Roberto C O Ferrania S P A Uff Brevetti | Film ottici comprendenti uno o piu' poliarilati ottenuti |
| WO2005082032A2 (en) * | 2004-02-23 | 2005-09-09 | Saegis Pharmaceuticals, Inc. | Treatment of attention disorders |
| CA2566204A1 (en) * | 2004-05-14 | 2005-12-01 | The Johns Hopkins University | Method for improving cognitive function by co-administration of a gabab receptor antagonist and an acetylcholinesterase inhibitor |
| WO2012126472A1 (en) * | 2011-03-18 | 2012-09-27 | Aarhus Universitet | Gaba-c receptor agonists or antagonists for use in the treatment of vascular diseases |
| IT201600098005A1 (it) * | 2016-09-29 | 2018-03-29 | Univ Degli Studi Roma La Sapienza | Analoghi e derivati di amminoacidi dicarbossilici come antibatterici |
| AU2018354090B2 (en) | 2017-10-23 | 2024-10-24 | Epitracker, Inc. | Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome |
| EP3796976A4 (de) | 2018-05-23 | 2022-03-30 | Epitracker, Inc. | Zusammensetzungen und verfahren zur diagnose und behandlung von alterungs- und langlebigen bedingungen |
| EP3908374A4 (de) * | 2019-01-09 | 2022-12-28 | Epitracker, Inc. | Zusammensetzungen und verfahren zur diagnose und behandlung von neurodegenerativen erkrankungen |
| JP7404382B2 (ja) | 2019-03-04 | 2023-12-25 | エピトラッカー インコーポレイテッド | 脂肪酸アナログ、ならびに認知機能障害、行動症状および慢性疼痛の処置におけるそれらの使用 |
| JP2024539823A (ja) | 2021-11-03 | 2024-10-31 | エピトラッカー インコーポレイテッド | 老化の質および寿命に関係する状態の治療のためのペンタデカノイルカルニチン |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL98502A (en) | 1990-06-22 | 1998-04-05 | Ciba Geigy Ag | Aminoalkane phosphinic acid derivatives, process for their preparation and pharmaceutical compositions containing them |
| EP0767174A1 (de) | 1991-11-21 | 1997-04-09 | Ciba-Geigy Ag | Neue Aminoalkanphosphinsäuren und ihre Salze |
| US5627169A (en) * | 1994-07-20 | 1997-05-06 | The Regents Of The University Of California | Selective antagonists for GABArho receptor |
-
1998
- 1998-06-23 US US09/446,721 patent/US6632806B1/en not_active Expired - Fee Related
- 1998-06-23 WO PCT/AU1998/000485 patent/WO1998058939A1/en not_active Ceased
- 1998-06-23 AU AU78993/98A patent/AU744189B2/en not_active Ceased
- 1998-06-23 DE DE69827635T patent/DE69827635T2/de not_active Expired - Fee Related
- 1998-06-23 EP EP98929133A patent/EP1000071B1/de not_active Expired - Lifetime
- 1998-06-23 AT AT98929133T patent/ATE282625T1/de not_active IP Right Cessation
-
2004
- 2004-05-06 AU AU2004201916A patent/AU2004201916A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1000071A4 (de) | 2001-02-28 |
| AU7899398A (en) | 1999-01-04 |
| WO1998058939A1 (en) | 1998-12-30 |
| AU2004201916A1 (en) | 2004-06-03 |
| EP1000071B1 (de) | 2004-11-17 |
| US6632806B1 (en) | 2003-10-14 |
| DE69827635D1 (de) | 2004-12-23 |
| DE69827635T2 (de) | 2006-02-02 |
| EP1000071A1 (de) | 2000-05-17 |
| AU744189B2 (en) | 2002-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69827635D1 (de) | Gaba-c-rezeptor-antagonisten zur stimulation des erinnerungsvermögens | |
| NO20042964L (no) | Spiroazasykliske forbindelser som monoaminreseptormodulatorer | |
| DE60022050D1 (de) | Metabotrope glutamatrezeptorantagonisten zur behandlung von krankheiten des zentralen nervensystems | |
| DE60029799D1 (de) | Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe | |
| CY1107682T1 (el) | Παραγωγα 4-τετραζολυλ-4 φαινυλπιπεριδινης για θεραπεια πονου | |
| DE60005560D1 (de) | Neuartiger p2x 7 rezeptor-antagonisten zur verwendung in der behandlung von entzündlichen, immuninduzierten erkrankungen oder erkrankungen des herz-kreislauf-systems | |
| TR199902942T2 (xx) | Nikotinik ACh Resept�rlerinde kolinerjik ligandlar olarak 8-Azabisiklo(3.2.1)okt-ene ve okstan t�revleri. | |
| EP0903349A3 (de) | CCR-3-Rezeptor-Antagonisten | |
| DE69912151D1 (de) | Carbonsäuren und carbonsäureisostere von n-heterocyclischen verbindungen | |
| ATE218854T1 (de) | Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin- abhängigen protein kinase | |
| ES2113081T3 (es) | 1,4-benzotiazepinas utiles como agentes neurologicos. | |
| DE60026568D1 (de) | Hydantoin derivate, pharmazeutische zusammensetzungen und verfahren zu ihrer verwendung | |
| TR200200066T2 (tr) | Migrenin tedavisi için seçici iGluR5 reseptör antagonistleri | |
| MY121054A (en) | Calcilytic compounds as calcium receptor antagonists. | |
| ATE357917T1 (de) | Behandlung von dyskinesie durch mu-selektive opioidantagonisten | |
| DE60008753D1 (de) | Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen | |
| TR199902192T2 (xx) | Anti-CDL40 bile�iklerinin tedavi ama�l� uygulama y�ntemleri | |
| ATE369348T1 (de) | Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie | |
| ATE320832T1 (de) | Behandlung von haarfollikeln mit neurokinin 1 rezeptor antagonisten | |
| DE60325965D1 (de) | Für die behandlung bzw. prevention von schmerzen geeignete triazaspiroverbindungen | |
| BR9810433A (pt) | Composições anti-helmìnticas | |
| ATE297739T1 (de) | Endothelin-antagonisten zur behandlung von herzversagen | |
| NZ533358A (en) | 3,4-Dihydro-1H-isoquinolin-2-yl-derivatives for use as NK2 receptor antagonists | |
| PL336897A1 (en) | Novel salts of bpc peptides, pharmaceutic compositions conatining them and method of obtaining such salts | |
| DE60017793D1 (de) | Verfahren zur vorbeugung und behandlung von beschädigung des schleimhautgewebes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |